Seana Carson - Bausch Health Exec Counsel

BVF Stock  EUR 7.24  0.05  0.70%   

Insider

Seana Carson is Exec Counsel of Bausch Health Companies
Age 51
Phone514-744-6792
Webhttps://www.bauschhealth.com

Seana Carson Latest Insider Activity

Tracking and analyzing the buying and selling activities of Seana Carson against Bausch Health stock is an integral part of due diligence when investing in Bausch Health. Seana Carson insider activity provides valuable insight into whether Bausch Health is net buyers or sellers over its current business cycle. Note, Bausch Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bausch Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Bausch Health Management Efficiency

The company has return on total asset (ROA) of 0.0338 % which means that it generated a profit of $0.0338 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8761) %, meaning that it generated substantial loss on money invested by shareholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities.
Bausch Health Companies has accumulated 22.65 B in total debt with debt to equity ratio (D/E) of 880.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bausch Health Companies has a current ratio of 1.07, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Bausch Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bausch Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bausch Health Companies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bausch to invest in growth at high rates of return. When we think about Bausch Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Gregory MaliassasPlaya Hotels Resorts
50
Parker HarrisSalesforce
56
David SchmaierSalesforce
N/A
Alexandre DayonSalesforce
55
Sarah FranklinSalesforce
N/A
Bret TaylorSalesforce
43
Dayna BlankPlaya Hotels Resorts
N/A
CFA CFAPlaya Hotels Resorts
N/A
Amy WeaverSalesforce
55
Tracy ColdenPlaya Hotels Resorts
62
Brent HyderSalesforce
58
Dean SullivanPlaya Hotels Resorts
N/A
Brian MillhamSalesforce
54
Srinivas TallapragadaSalesforce
53
Marc BenioffSalesforce
58
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada. BAUSCH HEALTH operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21100 people. Bausch Health Companies (BVF) is traded on Frankfurt Exchange in Germany and employs 19,900 people.

Management Performance

Bausch Health Companies Leadership Team

Elected by the shareholders, the Bausch Health's board of directors comprises two types of representatives: Bausch Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Health's management team and ensure that shareholders' interests are well served. Bausch Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Hartness, Commercial Access
Kathleen Fitzpatrick, VP Officer
John Barresi, Controller VP
Arthur Shannon, IR Contact Officer
Seana Carson, Exec Counsel
Tage MD, Chief RD
Robert Butz, VP Affairs
Thomas Appio, Executive Vice President and Presidentident - Asia Pacific
Thomas Vadaketh, Ex CFO
Mirza Dautbegovic, VP COO

Bausch Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bausch Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Bausch Stock

When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.